News and developments
Saraf and Partners, JMP advise on 360 ONE’s investment into House of Diagnostics Healthcare Private Limited
House of Diagnostics Healthcare Private Limited (“House of Diagnostics”), a leading provider of integrated diagnostics and imaging services in North India, has entered into definitive agreements with 360 ONE Alternates Asset Management Limited (“360 ONE”), acting as investment manager for 360 ONE investment schemes, for a minority investment by 360 ONE in House of Diagnostics. The transaction comprises a combination of primary and secondary investment by 360 ONE in House of Diagnostics.
Founded by Dr. Shubham Sogani and Labham Sogani, House of Diagnostics has established one of the leading integrated diagnostic networks in North India, centred around walk-in centres, home sample collection, and digitally enabled patient journeys. House of Diagnostics operates a network of 12 integrated diagnostic centres, supported by 200+ collection centres and home collection services, delivering industry-leading turnaround times and transparent pricing to consumers.
Saraf and Partners acted as legal counsel to House of Diagnostics and its promoter group, advising on all aspects of the transaction, including structuring, legal due diligence, drafting, negotiation, and finalization of the definitive agreements. The transaction team was led by Vaibhav Kakkar (Senior Partner), Sahil Arora (Partner) and Debarpan Ghosh (Partner), and consisted of Paayas Pandit (Senior Associate), Ishaan Gupta (Associate), Samiksha Bhargava (Associate), Krishna Lohia (Associate) and Suraj Kumar (Associate).
The due diligence team consisted of Sahil Arora (Partner) and Debarpan Ghosh (Partner), along with Paayas Pandit (Senior Associate), Ishaan Gupta (Associate), Devansh Sehgal (Associate), Nikhil Surana (Associate), Krishna Lohia (Associate) and Suraj Kumar (Associate).
Jerome Merchant + Partners advised the 360 ONE team.
House of Diagnostics plans to leverage the capital to expand into Mumbai, and other large diagnostic markets such as Hyderabad and Bangalore, with sophisticated patients who seek transparent pricing and prefer superior tech-enabled care.
